These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 3643827

  • 1. Study of elastase-type activity in blister fluids of recessive dystrophic epidermolysis bullosa.
    Francès C, Meimon G, Herson S, Robert L.
    Clin Physiol Biochem; 1986; 4(6):350-4. PubMed ID: 3643827
    [Abstract] [Full Text] [Related]

  • 2. Increased neutral protease and collagenase activity in recessive dystrophic epidermolysis bullosa.
    Takamori K, Naito K, Taneda A, Ogawa H.
    Br J Dermatol; 1983 Jun; 108(6):687-94. PubMed ID: 6305383
    [Abstract] [Full Text] [Related]

  • 3. Characterization of elastase-like enzymes in various blistering diseases.
    Oikarinen A, Kiistala U, Uitto J.
    Acta Derm Venereol; 1986 Jun; 66(1):1-5. PubMed ID: 2424207
    [Abstract] [Full Text] [Related]

  • 4. Proteases are responsible for blister formation in recessive dystrophic epidermolysis bullosa and epidermolysis bullosa simplex.
    Takamori K, Ikeda S, Naito K, Ogawa H.
    Br J Dermatol; 1985 May; 112(5):533-8. PubMed ID: 3890916
    [Abstract] [Full Text] [Related]

  • 5. Structural and functional properties of the dermoepidermal junction in obligate heterozygotes for recessive forms of epidermolysis bullosa.
    Tidman MJ, Eady RA.
    Arch Dermatol; 1986 Mar; 122(3):278-81. PubMed ID: 3954393
    [Abstract] [Full Text] [Related]

  • 6. [Epidermolysis bullosa].
    García Pérez A.
    An R Acad Nac Med (Madr); 1999 Mar; 116(2):387-413; discussion 413-5. PubMed ID: 10682398
    [Abstract] [Full Text] [Related]

  • 7. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)].
    Wirth H, Nesch A, Ostapowicz B, Anton-Lamprecht I.
    Z Hautkr; 1983 Apr 15; 58(8):555-74. PubMed ID: 6858283
    [Abstract] [Full Text] [Related]

  • 8. HLA and epidermolysis bullosa. Association between the HLA complex and recessive dystrophic epidermolysis bullosa.
    Vaidya S, Tyring SK, Johnson LB, Fine JD.
    Arch Dermatol; 1991 Oct 15; 127(10):1524-7. PubMed ID: 1929459
    [Abstract] [Full Text] [Related]

  • 9. [Syndromes 13. Epidermolysis bullosa].
    Meijndert L, Jonkman MF.
    Ned Tijdschr Tandheelkd; 1999 Aug 15; 106(8):302-5. PubMed ID: 11930425
    [Abstract] [Full Text] [Related]

  • 10. Protease inhibitor therapy for recessive dystrophic epidermolysis bullosa. In vitro effect and clinical trial with camostat mesylate.
    Ikeda S, Manabe M, Muramatsu T, Takamori K, Ogawa H.
    J Am Acad Dermatol; 1988 Jun 15; 18(6):1246-52. PubMed ID: 3385039
    [Abstract] [Full Text] [Related]

  • 11. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
    Smoller BA, McNutt NS, Carter DM, Gottlieb AB, Hsu A, Krueger J.
    Arch Dermatol; 1990 Jan 15; 126(1):78-83. PubMed ID: 1688702
    [Abstract] [Full Text] [Related]

  • 12. Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase.
    Bauer EA, Cooper TW, Tucker DR, Esterly NB.
    N Engl J Med; 1980 Oct 02; 303(14):776-81. PubMed ID: 6251365
    [Abstract] [Full Text] [Related]

  • 13. Persistent subepidermal blistering in split-thickness skin graft sites. Ultrastructural and antigenic features simulating dystrophic or immunofluorescence-negative acquired epidermolysis bullosa.
    Epstein A, Hendrick SJ, Sanchez RL, Solomon AR, Fine JD.
    Arch Dermatol; 1988 Feb 02; 124(2):244-9. PubMed ID: 3277544
    [Abstract] [Full Text] [Related]

  • 14. "Sporadic" dystrophic epidermolysis bullosa: a new dominant or mitis recessive mutation?
    Vaccaro M, Moretti G, Guarneri F, Cannavò S, Magaudda L.
    Eur J Dermatol; 2000 Aug 02; 10(6):436-8. PubMed ID: 10980463
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis. A comparison of short- and long-term treatment.
    Cooper TW, Bauer EA.
    Arch Dermatol; 1984 Apr 02; 120(4):490-5. PubMed ID: 6703753
    [Abstract] [Full Text] [Related]

  • 16. Compound heterozygosity for a nonsense mutation and a splice site mutation in the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa.
    Tamai K, Ishida-Yamamoto A, Matsuo S, Iizuka H, Hashimoto I, Christiano AM, Uitto J, McGrath JA.
    Lab Invest; 1997 Feb 02; 76(2):209-17. PubMed ID: 9042157
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Autosomal recessive albopapuloid dystrophic epidermolysis bullosa].
    Ramelet AA, Boillat C.
    Dermatologica; 1985 Feb 02; 171(6):397-406. PubMed ID: 4092794
    [Abstract] [Full Text] [Related]

  • 19. Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa.
    Christiano AM, Anhalt G, Gibbons S, Bauer EA, Uitto J.
    Genomics; 1994 May 01; 21(1):160-8. PubMed ID: 8088783
    [Abstract] [Full Text] [Related]

  • 20. Increased levels of matrix metalloproteinase-9 and interleukin-8 in blister fluids of dystrophic and junctional epidermolysis bullosa patients.
    Lettner T, Lang R, Bauer JW, Wally V.
    J Eur Acad Dermatol Venereol; 2015 Feb 01; 29(2):396-398. PubMed ID: 24533594
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.